DrugPatentWatch Database Preview

Bayer Healthcare Company Profile

Email this page to a colleague

BAYER HEALTHCARE has thirty approved drugs.

There are nineteen US patents protecting BAYER HEALTHCARE drugs.

There are three hundred and eleven patent family members on BAYER HEALTHCARE drugs in fifty-five countries and twelve supplementary protection certificates in eight countries.

International Patents:	311
US Patents:	19
Tradenames:	24
Ingredients:	14
NDAs:	30
Patent Litigation for Bayer Healthcare:	See patent lawsuits for Bayer Healthcare

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Healthcare	VITRAKVI	larotrectinib sulfate	SOLUTION;ORAL	211710-001	Nov 26, 2018		RX	Yes	Yes	8,865,698	Start Trial				Start Trial
Bayer Healthcare Llc	CHLOR-TRIMETON	chlorpheniramine maleate; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	018397-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		Start Trial				Start Trial
Bayer Healthcare	ALIQOPA	copanlisib dihydrochloride	POWDER;INTRAVENOUS	209936-001	Sep 14, 2017		RX	Yes	Yes	10,383,876	Start Trial	Y	Y		Start Trial
Bayer Healthcare Llc	CHILDREN'S CLARITIN	loratadine	TABLET, CHEWABLE;ORAL	021891-001	Aug 23, 2006		OTC	Yes	Yes		Start Trial				Start Trial
Bayer Healthcare Llc	GYNE-LOTRIMIN	clotrimazole	TABLET;VAGINAL	017717-002	Nov 30, 1990		DISCN	Yes	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Healthcare Llc	CLARITIN	loratadine	TABLET;ORAL	019658-002	Nov 27, 2002	4,659,716*PED	Start Trial
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992	4,387,089	Start Trial
Bayer Healthcare Llc	ZEGERID OTC	omeprazole; sodium bicarbonate	CAPSULE;ORAL	022281-001	Dec 1, 2009	6,699,885	Start Trial
Bayer Healthcare Llc	ZEGERID OTC	omeprazole; sodium bicarbonate	CAPSULE;ORAL	022281-001	Dec 1, 2009	6,489,346	Start Trial
Bayer Healthcare Llc	ZEGERID OTC	omeprazole; sodium bicarbonate	FOR SUSPENSION;ORAL	022283-001	Jun 17, 2013	7,399,772	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	20 mg/1100 mg	➤ Subscribe	2010-04-20

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3106463	PA2020504	Lithuania	Start Trial	PRODUCT NAME: LAROTREKTINIBAS IR (ARBA) FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, YPAC LAROTREKTINIBO SULFATAS, ISKAITANT LAROTREKTINIBO VANDENILIO SULFATA; REGISTRATION NO/DATE: EU/1/19/1385 20190919
0152897	2001C/013	Belgium	Start Trial	PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115
3106463	301033	Netherlands	Start Trial	PRODUCT NAME: LAROTRECTINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LAROTRECTINIBSULFAAT, MET INBEGRIP VAN LAROTRECTINIBSULFAAT MONOHYDRAAT; REGISTRATION NO/DATE: EU/1/19/1385 20190923
1110543	08C0004	France	Start Trial	PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
1411900	SPC/GB11/015	United Kingdom	Start Trial	PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.